Alzheimers New Drug Approved by FDA Storyboard
खोज

Alzheimers New Drug Approved by FDA

एक स्टोरीबोर्ड बनाएँ
इस स्टोरीबोर्ड को कॉपी करें
Alzheimers New Drug Approved by FDA
अपना खुद का बनाओ! प्रतिलिपि

स्टोरीबोर्ड विवरण

PME 815

स्टोरीबोर्ड पाठ

  • फिसलना: 1
  • News Stand
  • “Alzheimer’s Cure Approved by FDA – Only One Pill Needed!”
  • फिसलना: 2
  • “Wow, I should share this!” -- Texts a friend
  • फिसलना: 3
  • “Are you sure it’s real? We should use facts checking tools, try to find the original source and verify and check other sources just to make sure.”
  • Skepticism ensues....
  • फिसलना: 4
  • Searches for information on the FDA’s website, discovering that the new Alzheimer’s treatment, Lecanemab, is not a cure and has limitations.
  • FDA
  • फिसलना: 5
  • Let's consult the Mayo Clinic . They found that Lecanemab slows symptoms in early cases but has severe risks, including brain swelling.
  • फिसलना: 6
  • “Imagine if social media flagged questionable health news and provided a ‘Read More’ option to check reliable sources.”
  • Maybe platforms could highlight credible sources when using information from them .
  • फिसलना: 7
  • Another source shows the drug costs $26,500 annually. That’s not affordable for everyone, jeepers!
  • फिसलना: 8
  • So basically, Lecanemab helps some early-stage patients but isn’t a cure, comes with risks, and is expensive.
  • फिसलना: 9
  • “To be a responsible digital citizen, always verify health claims and question headlines.”
  • फिसलना: 10
  • Sources:Alzheimer's Association. “Donanemab for Treatment of Early Alzheimer’s Disease — News Pending FDA Review.” Alzheimer’s Disease and Dementia, 2023, www.alz.org/alzheimers-dementia/treatments/donanemab. Canadian Teachers’ Federation. (2021, February 22). Break the fake [Video]. YouTube. https://www.youtube.com/watch?v=qHeNabULAE0 Salam, Erum. “FDA Approves Breakthrough Alzheimer’s Drug Lecanemab.” The Guardian, 6 Jan. 2023, www.theguardian.com/us-news/2023/jan/06/fda-approves-breakthrough-alzheimers-drug-lecanemab.Stiepan, DeeDee. “Alzheimer’s Drug Lecanemab Granted Full Approval by FDA, Mayo Clinic Expert Weighs In.” Mayo Clinic News Network, 6 July 2023, newsnetwork.mayoclinic.org/discussion/alzheimers-drug-lecanemab-granted-full-approval-by-fda-mayo-clinic-expert-weighs-in/.
40 मिलियन से अधिक स्टोरीबोर्ड बनाए गए
कोई डाउनलोड नहीं, कोई क्रेडिट कार्ड नहीं, और कोशिश करने के लिए किसी लॉगिन की आवश्यकता नहीं है!
मेरा पहला स्टोरीबोर्ड बनाएं
Storyboard That फैमिली